These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1446923)
21. Fine-mapping of the B-cell epitope domain at the N-terminus of the preS2 region of the hepatitis B surface antigen. Sominskaya I; Paulij W; Jansons J; Sobotta D; Dreilina D; Sunnen C; Meisel H; Gerlich WH; Pumpens P J Immunol Methods; 2002 Feb; 260(1-2):251-61. PubMed ID: 11792393 [TBL] [Abstract][Full Text] [Related]
22. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site. Cupps TR; Tibbles J; Hurni WM; Miller WJ; Ellis RW; Milich D; Wetter N J Immunol; 1993 Sep; 151(6):3353-60. PubMed ID: 7690803 [TBL] [Abstract][Full Text] [Related]
23. Gene fusion of cholera toxin B subunit and HBV PreS2 epitope and the antigenicity of fusion protein. Shi CH; Cao C; Xhig JS; Li J; Ma QJ Vaccine; 1995 Jul; 13(10):933-7. PubMed ID: 7483767 [TBL] [Abstract][Full Text] [Related]
24. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China]. Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927 [TBL] [Abstract][Full Text] [Related]
25. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757 [TBL] [Abstract][Full Text] [Related]
26. Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide. Rajadhyaksha M; Thanavala Y Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1575-9. PubMed ID: 7878021 [TBL] [Abstract][Full Text] [Related]
27. Immunodominance of a recombinant T-cell epitope depends on its molecular environment. Leclerc C; Martineau P; Charbit A; Lo-Man R; Dériaud E; Hofnung M Mol Immunol; 1993 Dec; 30(17):1561-72. PubMed ID: 8247026 [TBL] [Abstract][Full Text] [Related]
28. Antibody responses to preS components after immunization of children with low doses of BioHepB. Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751 [TBL] [Abstract][Full Text] [Related]
29. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866 [TBL] [Abstract][Full Text] [Related]
30. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies. Golsaz-Shirazi F; Mohammadi H; Amiri MM; Khoshnoodi J; Kardar GA; Jeddi-Tehrani M; Shokri F Arch Virol; 2016 Oct; 161(10):2765-72. PubMed ID: 27439498 [TBL] [Abstract][Full Text] [Related]
31. Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide. Waters J; Pignatelli M; Galpin S; Ishihara K; Thomas HC J Gen Virol; 1986 Nov; 67 ( Pt 11)():2467-73. PubMed ID: 2431101 [TBL] [Abstract][Full Text] [Related]
32. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes. Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811 [TBL] [Abstract][Full Text] [Related]
33. Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Neurath AR; Kent SB; Strick N Science; 1984 Apr; 224(4647):392-5. PubMed ID: 6200931 [TBL] [Abstract][Full Text] [Related]
34. Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen. Chi SW; Kim DH; Kim JS; Lee MK; Han KH Antiviral Res; 2006 Dec; 72(3):207-15. PubMed ID: 16872688 [TBL] [Abstract][Full Text] [Related]
35. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975 [TBL] [Abstract][Full Text] [Related]
36. Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles. Belyaev AS; Roy P Virology; 1992 Oct; 190(2):840-4. PubMed ID: 1381538 [TBL] [Abstract][Full Text] [Related]
38. Unique preS sequence in a gibbon-derived hepatitis B virus variant. Mimms LT; Solomon LR; Ebert JW; Fields H Biochem Biophys Res Commun; 1993 Aug; 195(1):186-91. PubMed ID: 8363598 [TBL] [Abstract][Full Text] [Related]
39. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Bckström M; Holmgren J; Schödel F; Lebens M Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171 [TBL] [Abstract][Full Text] [Related]
40. Humoral Immune Response in Mice Elicited by Combined Yeast-Derived Hepatitis B Virus Core, Surface, and Mosaic Surface Antigens. Granovski V; Yokosawa J; Rodrigues-Granovski V; Castro CC; Urbina AC; Granovski N Intervirology; 2017; 60(3):90-101. PubMed ID: 28957812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]